Advertisement
Commentary| Volume 86, ISSUE 12, P874-876, December 15, 2019

Angiotensin II Signaling and Fear Extinction: Translational Evidence and Novel Receptor Targets

      SEE CORRESPONDING ARTICLES ON PAGES 899 AND 910
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lebois L.A.M.
        • Seligowski A.V.
        • Wolff J.D.
        • Hill S.B.
        • Ressler K.J.
        Augmentation of extinction and inhibitory learning in anxiety and trauma-related disorders.
        Annu Rev Clin Psychol. 2019; 15: 257-284
        • Yu Z.
        • Swiercz A.P.
        • Moshfegh C.M.
        • Hopkins L.
        • Wiaderkiewicz J.
        • Speth R.C.
        • et al.
        Angiotensin II type 2 receptor–expressing neurons in the central amygdala influence fear-related behavior.
        Biol Psychiatry. 2019; 86: 899-909
        • Zhou F.
        • Geng Y.
        • Xin F.
        • Li J.
        • Feng P.
        • Liu C.
        • et al.
        Human extinction learning is accelerated by an angiotensin antagonist via ventromedial prefrontal cortex and its connections with basolateral amygdala.
        Biol Psychiatry. 2019; 86: 910-920
        • Shekhar A.
        Angiotensin type 1 receptor antagonists-A novel approach to augmenting posttraumatic stress disorder and phobia therapies?.
        Biol Psychiatry. 2014; 75: 836-837
        • Karnik S.S.
        • Unal H.
        • Kemp J.R.
        • Tirupula K.C.
        • Eguchi S.
        • Vanderheyden P.M.L.
        • Thomas W.G.
        International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin receptors: Interpreters of pathophysiological angiotensinergic stimuli [corrected].
        Pharmacol Rev. 2015; 67: 754-819
        • Jackson L.
        • Eldahshan W.
        • Fagan S.C.
        • Ergul A.
        Within the brain: The renin angiotensin system.
        Int J Mol Sci. 2018; 19: E876
        • Khoury N.M.
        • Marvar P.J.
        • Gillespie C.F.
        • Wingo A.
        • Schwartz A.
        • Bradley B.
        • et al.
        The renin-angiotensin pathway in posttraumatic stress disorder: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms.
        J Clin Psychiatry. 2012; 73: 849-855
        • Nylocks K.M.
        • Michopoulos V.
        • Rothbaum A.O.
        • Almli L.
        • Gillespie C.F.
        • Wingo A.
        • et al.
        An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.
        Am J Med Genet B Neuropsychiatr Genet. 2015; 168B: 307-315
        • Marvar P.J.
        • Goodman J.
        • Fuchs S.
        • Choi D.C.
        • Banerjee S.
        • Ressler K.J.
        Angiotensin type 1 receptor inhibition enhances the extinction of fear memory.
        Biol Psychiatry. 2014; 75: 864-872
        • Hurt R.C.
        • Garrett J.C.
        • Keifer Jr., O.P.
        • Linares A.
        • Couling L.
        • Speth R.C.
        • et al.
        Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear.
        Genes Brain Behav. 2015; 14: 526-533

      Linked Article

      CHORUS Manuscript

      View Open Manuscript